Bone marrow stromal cell-derived Wnt signals as a potential underlying mechanism for cyclin D1 deregulation in multiple myeloma lacking t(11;14)(q13;q32)

被引：9

作者：

Bueno, Clara ^{[1
]}

Lopes, Luiz F. ^{[1
]}

Menendez, Pablo ^{[1
]}

机构：

[1] Inst Invest Biomed, Andalusian Stem Cell Bank, Granada, Spain

来源：

BLOOD CELLS MOLECULES AND DISEASES | 2007年 / 39卷 / 03期

关键词：

D O I：

10.1016/j.bcmd.2007.06.001

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：366 / 368

页数：3

共 9 条

[1] Insights into the multistep transformation of MGUS to myeloma using microarray expression analysis [J].

Davies, FE ;

Dring, AM ;

Li, C ;

Rawstron, AC ;

Shammas, MA ;

O'Connor, SM ;

Fenton, JAL ;

Hideshima, T ;

Chauhan, D ;

Tai, IT ;

Robinson, E ;

Auclair, D ;

Rees, K ;

Gonzalez, D ;

Ashcroft, AJ ;

Dasgupta, R ;

Mitsiades, C ;

Mitsiades, N ;

Chen, LB ;

Wong, WH ;

Munshi, NC ;

Morgan, GJ ;

Anderson, KC .

BLOOD, 2003, 102 (13) :4504-4511

[2] Illegitimate WNT signaling promotes proliferation of multiple myeloma cells [J].

Derksen, PWB ;

Tjin, E ;

Meijer, HP ;

Klok, MD ;

Mac Gillavry, HD ;

van Oers, MHJ ;

Lokhorst, HM ;

Bloem, AC ;

Clevers, H ;

Nusse, R ;

van der Neut, R ;

Spaargaren, M ;

Pals, ST .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (16) :6122-6127

[3] Molecular mechanisms of novel therapeutic approaches for multiple myeloma [J].

Hideshima, T ;

Anderson, KC .

NATURE REVIEWS CANCER, 2002, 2 (12) :927-937

[4] Advances in biology of multiple myeloma: clinical applications [J].

Hideshima, T ;

Bergsagel, PL ;

Kuehl, WM ;

Anderson, KC .

BLOOD, 2004, 104 (03) :607-618

[5]

Khan NI, 2006, HISTOL HISTOPATHOL, V21, P761, DOI 10.14670/HH-21.761

[6] A long-term study of prognosis in monoclonal gammopathy of undetermined significance [J].

Kyle, RA ;

Therneau, TM ;

Rajkumar, SV ;

Offord, JR ;

Larson, DR ;

Plevak, MF ;

Melton, L .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (08) :564-569

[7] Focus on multiple myeloma [J].

Mitsiades, CS ;

Mitsiades, N ;

Munshi, NC ;

Anderson, KC .

CANCER CELL, 2004, 6 (05) :439-444

[8] Myeloma cells suppress bone formation by secreting a soluble Wnt inhibitor, sFRP-2 [J].

Oshima, T ;

Abe, M ;

Asano, J ;

Hara, T ;

Kitazoe, K ;

Sekimoto, E ;

Tanaka, Y ;

Shibata, H ;

Hashimoto, T ;

Ozaki, S ;

Kido, S ;

Inoue, D ;

Matsumoto, T .

BLOOD, 2005, 106 (09) :3160-3165

[9] The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma [J].

Tian, E ;

Zhan, FH ;

Walker, R ;

Rasmussen, E ;

Ma, YP ;

Barlogie, B ;

Shaughnessy, JD .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (26) :2483-2494

← 1 →